Related Experiment Videos
Insights
Paregoric intoxication can cause pulmonary edema in infants. Due to unclear medical benefits and serious risks, paregoric use in children should be discontinued.
Area of Science:
- Pediatric Medicine
- Toxicology
- Pharmacology
Background:
- Paregoric, a camphorated tincture of opium, has been historically used for various pediatric ailments.
- The precise mechanisms underlying opioid-induced pulmonary edema are not fully understood.
- Concerns exist regarding the safety and efficacy of paregoric in infants.
Observation:
- A case study of a 3-week-old infant presenting with paregoric intoxication.
- The infant developed significant pulmonary edema secondary to paregoric exposure.
- Clinical presentation and management of the infant's respiratory distress.
Findings:
- Opioid use, including paregoric, is associated with potentially treatable pulmonary edema.
- The exact pathophysiology of opioid-induced pulmonary edema remains elusive.
- The clinical indication for using paregoric in pediatric patients is questionable.
Implications:
- The findings suggest that paregoric poses serious risks, such as pulmonary edema, in infants.
- Abandoning the use of paregoric in pediatric patients is recommended due to severe complications.
- Further research into the mechanisms of opioid-induced pulmonary edema is warranted.
Abstract:
This report describes a 3-week-old infant with paregoric intoxication and pulmonary edema. The pulmonary edema associated with opiod use is treatable even though the precise mechanism of its formation remains undefined. The report emphasizes that the medical rationale involved in the use of paregoric is unclear. The use of this preparation in pediatric patients should be abandoned in view of such serious complications.